Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Goodwill & Intangibles (2016 - 2026)

Niagen Bioscience has reported Goodwill & Intangibles over the past 14 years, most recently at $5.7 million for Q4 2025.

  • Quarterly Goodwill & Intangibles rose 1476.6% to $5.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, up 1476.6% year-over-year, with the annual reading at $5.7 million for FY2025, 1476.6% up from the prior year.
  • Goodwill & Intangibles was $5.7 million for Q4 2025 at Niagen Bioscience, up from $246000.0 in the prior quarter.
  • Over five years, Goodwill & Intangibles peaked at $5.7 million in Q4 2025 and troughed at $246000.0 in Q3 2025.
  • The 5-year median for Goodwill & Intangibles is $591000.0 (2023), against an average of $849210.5.
  • The largest YoY upside for Goodwill & Intangibles was 1476.6% in 2025 against a maximum downside of 38.04% in 2025.
  • A 5-year view of Goodwill & Intangibles shows it stood at $857000.0 in 2021, then decreased by 21.7% to $671000.0 in 2022, then fell by 23.99% to $510000.0 in 2023, then decreased by 29.61% to $359000.0 in 2024, then soared by 1476.6% to $5.7 million in 2025.
  • Per Business Quant, the three most recent readings for NAGE's Goodwill & Intangibles are $5.7 million (Q4 2025), $246000.0 (Q3 2025), and $284000.0 (Q2 2025).